"A refined scholarly book-promotion image showing an open ancient-text study book, connected genealogy lines, manuscript-inspired symbols, and a clear space for headline text."Daniel Harrow announces ...
Exactly 68 schools — the same number of athletic programs in the four biggest conferences in Division I — reached or came within 5% of reaching the $20.5 million revenue-sharing cap over the first ...
Albertsons® Companies, Inc. (NYSE: ACI) today announced the appointment of Bill Boltz, Chris Drumgoole and Meg Ham to the company’s Board of Directors effective Oct. 14, 2026. The three new directors ...
If approved, Joenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or more Decision follows recent approval of Joenja for children aged 4 to 11 years with ...
FDA accepts leniolisib sNDA with priority review for children with APDS aged 4+ weighing 13 to <27 kg; PDUFA date is January 30, 2027. Children with activated phosphoinositide 3-kinase δ syndrome ...
Leiden, the Netherlands, September 25, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the U.S ...
Pharming announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) seeking approval for lower doses of Joenja® (leniolisib), an oral, ...
Pharming’s sNDA acceptance for lower-dose Joenja underscores its strategic focus on expanding treatment options for rare immune diseases, particularly in underserved pediatric populations. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results